Detalhe da pesquisa
1.
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.
Eur J Haematol
; 112(4): 547-553, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116695
2.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Br J Haematol
; 197(3): 293-301, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35064676
3.
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
Br J Haematol
; 192(6): 997-1005, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798327
4.
Survival trends in elderly myeloma patients.
Eur J Haematol
; 106(1): 126-131, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33037667
5.
Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet Oncol
; 20(12): 1760-1772, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668592
6.
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma.
Haematologica
; 109(6): 1960-1965, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38268439
7.
Guidelines for screening and management of late and long-term consequences of myeloma and its treatment.
Br J Haematol
; 176(6): 888-907, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28107574
8.
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
Br J Haematol
; 196(1): 95-98, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341984
9.
Levofloxacin prophylaxis in patients with myeloma - Authors' reply.
Lancet Oncol
; 21(2): e69, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007200
10.
Time to redefine Myeloma.
Br J Haematol
; 171(1): 1-10, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26221971
11.
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels.
Haematologica
; 105(4): e169-e171, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31399530
12.
The combination of an inclusive novel agent treatment strategy, pre-emptive therapy dose reduction, and prolonged therapy results in good outcomes in elderly myeloma patients.
Br J Haematol
; 186(3): e11-e13, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30864155
13.
Patient-reported symptoms and diagnostic journey in Multiple Myeloma.
Front Oncol
; 13: 1282569, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098501
14.
An Economic Model to Establish the Costs Associated With Routes to Presentation for Patients With Multiple Myeloma in the United Kingdom.
Value Health Reg Issues
; 35: 27-33, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36841011
15.
Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial.
Cancers (Basel)
; 15(13)2023 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444449
16.
Cryptococcosis in late stage multiple myeloma: consider it.
Br J Haematol
; 176(5): 687, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28109161
17.
High numbers of COVID-19 patients transit through non-COVID wards, and associated healthcare workers have high infection rates: An observational cross-sectional study.
PLoS One
; 17(10): e0275154, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260597
18.
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial.
BMJ Open
; 12(6): e056147, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654466
19.
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management.
Blood Cancer J
; 10(11): 114, 2020 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33149136
20.
Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT.
Health Technol Assess
; 23(62): 1-94, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31690402